KEB Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

KEB Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.6K	Buy	+600	New	+$34.5K	0.01%	114
2024 Q2	–	Sell	-4,300	Closed	-$233K	–	71
2024 Q1	$233K	Hold	4,300	–	–	0.08%	63
2023 Q4	$221K	Hold	4,300	–	–	0.08%	64
2023 Q3	$250K	Hold	4,300	–	–	0.1%	52
2023 Q2	$275K	Hold	4,300	–	–	0.11%	47
2023 Q1	$298K	Hold	4,300	–	–	0.13%	44
2022 Q4	$309K	Sell	4,300 -24	-0.6%	-$1.81K	0.16%	42
2022 Q3	$307K	Buy	4,324 +24	+0.6%	+$1.74K	0.2%	37
2022 Q2	$331K	Buy	+4,300	New	+$327K	0.21%	34
2022 Q1	–	Sell	-4,552	Closed	-$284K	–	45
2021 Q4	$284K	Buy	+4,552	New	+$267K	0.18%	38

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

KEB Asset Management's BMY Position: Q2 2026 in Review

KEB Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 600 shares worth $34.6K. The stake represents 0.01% of the portfolio and ranks #114 among its holdings. This is a return to the name: KEB Asset Management previously reported a position in BMY as recently as Q1 2024.

KEB Asset Management first reported a position in BMY in Q4 2021 and has held it in 10 quarters since. The position peaked at $331K in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

KEB Asset Management held 600 shares of Bristol-Myers Squibb worth $34.6K as of Q2 2026.
Bristol-Myers Squibb was a new KEB Asset Management position in Q2 2026.
Bristol-Myers Squibb made up 0.01% of KEB Asset Management's portfolio in Q2 2026, its #114 holding.
KEB Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 10 quarters since.
KEB Asset Management's Bristol-Myers Squibb position peaked at $331K in Q2 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on KEB Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.